טוען...

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study

BACKGROUND: Pancreatic adenocarcinoma is a high-mortality neoplasm with a documented 5-years-overall survival around 5%. In the last decades, a real breakthrough in the treatment of the disease has not been achieved. Here we propose a prospective, phase II, multicentre, single-arm study aiming to as...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	BMC Cancer
Main Authors:	Vitolo, Viviana, Cobianchi, Lorenzo, Brugnatelli, Silvia, Barcellini, Amelia, Peloso, Andrea, Facoetti, Angelica, Vanoli, Alessandro, Delfanti, Sara, Preda, Lorenzo, Molinelli, Silvia, Klersy, Catherine, Fossati, Piero, Orecchia, Roberto, Valvo, Francesca
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BioMed Central 2019
נושאים:	Study Protocol
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6744648/ https://ncbi.nlm.nih.gov/pubmed/31521134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6108-0
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study

פריטים דומים